Principal Infrastructure Engineer, Genesis Therapeutics
+ Equity
Unifying AI and biotechnology for drug discovery
Open for applications
Unifying AI and biotechnology for drug discovery
21-100 employees
Open for applications
+ Equity
21-100 employees
Company mission
To transform small molecule drug discovery to solve critical patient needs.
Role
Who you are
- 5+ years of experience building and maintaining cloud infrastructure at scale, e.g. within AWS or GCP
- Proficient with Python, Bash, Terraform, and Kubernetes
- Ideally, experience building and maintaining compute clusters running distributed ML training jobs with 1,000+ GPUs
- Nice to have: hands-on experience with physical hardware + datacenter management
What the job involves
- We are looking for a Principal Infrastructure Engineer that is excited to help develop new medicines and play a critical role in building out our AI platform
- Lead our infrastructure team to maintain and grow our multi-cloud compute infrastructure that supports our ML model training, computational chemistry research, and ongoing drug discovery efforts
- Build out our configuration and procedures for monitoring, resource allocation, and deployment automation, as we continue to grow our autoscaling compute clusters to handle larger workloads
- Work on improvements to our internal job scheduling system to increase our execution throughput, reliability, and compute utilization across heterogeneous pipelines
Our take
Genesis Therapeutics is at the forefront of advancing drug creation to foster better healthcare outcomes. the company offers an AI-powered molecule discovery platform, known as GEMS, designed to empower medical researchers. By seamlessly integrating AI with biotech, GEMS leverages deep learning and molecular simulations to explore uncharted territories within chemical space, unveiling novel opportunities for functional drugs.
Boasted to be the "industry's most advanced molecular AI platform", GEMS accelerates the discovery of small molecules while also enhancing potency and selectivity. This breakthrough capability not only expedites the development process but also paves the way for creating medications targeting previously inaccessible domains.
With significant funding backing its endeavours, Genesis Therapeutics is poised to transition into clinical testing. Moreover, the company aims to broaden the scope of its platform, extending its reach to encompass a wider array of therapeutic targets.
Kirsty
Company Specialist
Insights
Company
Funding (last 2 of 3 rounds)
Aug 2023
$224.1m
SERIES B
Dec 2020
$52m
SERIES A
Total funding: $280.2m
Company benefits
- Stock Option Eligibility
- 401(k) Plan
- Open PTO Policy
- Paid Company Holidays
- Free lunch and snacks at our offices
- Health Care Plan, including Medical, Dental, and Vision, fully covered for the employees
Company HQ
Country Club Manor, Hillsborough, CA
Articles
Leadership
Evan Feinberg
(CEO)PhD Graduate from Stanford, where they were an Algorithm Developer, collaborating with the Office of Technology Licensing to develop BraneRank (which uses graph substructures to rank search results). Was then a Deep Learning Consultant for Merck for 11 months.
Ben Sklaroff
(CTO)Graduated from UC Berkeley with a degree in Electrical Engineering and Computer Science. Worked at Markforged for 3 years, ultimately as Director of Software Engineering.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 6 more jobs at Genesis Therapeutics